Logo image of NVJP.DE

UMICORE (NVJP.DE) Stock Fundamental Analysis

Europe - FRA:NVJP - BE0974320526 - Common Stock

17.36 EUR
+0.23 (+1.34%)
Last: 11/13/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NVJP. NVJP was compared to 67 industry peers in the Chemicals industry. While NVJP is still in line with the averages on profitability rating, there are concerns on its financial health. NVJP is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year NVJP was profitable.
NVJP had a positive operating cash flow in the past year.
Of the past 5 years NVJP 4 years were profitable.
In the past 5 years NVJP always reported a positive cash flow from operatings.
NVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFNVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

NVJP has a Return On Assets (1.50%) which is comparable to the rest of the industry.
With a decent Return On Equity value of 6.30%, NVJP is doing good in the industry, outperforming 61.19% of the companies in the same industry.
NVJP has a Return On Invested Capital of 6.40%. This is in the better half of the industry: NVJP outperforms 67.16% of its industry peers.
Industry RankSector Rank
ROA 1.5%
ROE 6.3%
ROIC 6.4%
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
NVJP.DE Yearly ROA, ROE, ROICNVJP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

NVJP's Profit Margin of 0.80% is in line compared to the rest of the industry. NVJP outperforms 49.25% of its industry peers.
The Operating Margin of NVJP (2.57%) is comparable to the rest of the industry.
NVJP has a Gross Margin of 7.76%. This is amonst the worse of the industry: NVJP underperforms 80.60% of its industry peers.
NVJP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.57%
PM (TTM) 0.8%
GM 7.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
NVJP.DE Yearly Profit, Operating, Gross MarginsNVJP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NVJP is still creating some value.
NVJP has about the same amout of shares outstanding than it did 1 year ago.
NVJP has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, NVJP has a worse debt to assets ratio.
NVJP.DE Yearly Shares OutstandingNVJP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NVJP.DE Yearly Total Debt VS Total AssetsNVJP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 2.81 indicates that NVJP is not a great score, but indicates only limited risk for bankruptcy at the moment.
NVJP has a better Altman-Z score (2.81) than 67.16% of its industry peers.
The Debt to FCF ratio of NVJP is 50.79, which is on the high side as it means it would take NVJP, 50.79 years of fcf income to pay off all of its debts.
NVJP has a Debt to FCF ratio of 50.79. This is comparable to the rest of the industry: NVJP outperforms 50.75% of its industry peers.
A Debt/Equity ratio of 1.10 is on the high side and indicates that NVJP has dependencies on debt financing.
NVJP has a Debt to Equity ratio of 1.10. This is amonst the worse of the industry: NVJP underperforms 82.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 50.79
Altman-Z 2.81
ROIC/WACC1.05
WACC6.1%
NVJP.DE Yearly LT Debt VS Equity VS FCFNVJP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

NVJP has a Current Ratio of 1.37. This is a normal value and indicates that NVJP is financially healthy and should not expect problems in meeting its short term obligations.
NVJP has a worse Current ratio (1.37) than 70.15% of its industry peers.
NVJP has a Quick Ratio of 1.37. This is a bad value and indicates that NVJP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.72, NVJP is not doing good in the industry: 77.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.72
NVJP.DE Yearly Current Assets VS Current LiabilitesNVJP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

NVJP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.12%.
NVJP shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.85% yearly.
The Revenue has been growing slightly by 2.55% in the past year.
Measured over the past years, NVJP shows a decrease in Revenue. The Revenue has been decreasing by -3.21% on average per year.
EPS 1Y (TTM)-18.12%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%14.29%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-0.72%

3.2 Future

The Earnings Per Share is expected to grow by 10.30% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.05% on average over the next years.
EPS Next Y18.79%
EPS Next 2Y13.5%
EPS Next 3Y11.09%
EPS Next 5Y10.31%
Revenue Next Year-2.96%
Revenue Next 2Y2%
Revenue Next 3Y1.1%
Revenue Next 5Y2.05%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVJP.DE Yearly Revenue VS EstimatesNVJP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
NVJP.DE Yearly EPS VS EstimatesNVJP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.36, the valuation of NVJP can be described as correct.
Based on the Price/Earnings ratio, NVJP is valued a bit cheaper than 74.63% of the companies in the same industry.
When comparing the Price/Earnings ratio of NVJP to the average of the S&P500 Index (25.89), we can say NVJP is valued slightly cheaper.
NVJP is valuated correctly with a Price/Forward Earnings ratio of 12.71.
NVJP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NVJP is cheaper than 73.13% of the companies in the same industry.
NVJP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.59.
Industry RankSector Rank
PE 15.36
Fwd PE 12.71
NVJP.DE Price Earnings VS Forward Price EarningsNVJP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

65.67% of the companies in the same industry are more expensive than NVJP, based on the Enterprise Value to EBITDA ratio.
NVJP's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 75.83
EV/EBITDA 8.63
NVJP.DE Per share dataNVJP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

NVJP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y13.5%
EPS Next 3Y11.09%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.14%, NVJP has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.26, NVJP pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, NVJP has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.14%

5.2 History

The dividend of NVJP has a limited annual growth rate of 0.67%.
Dividend Growth(5Y)0.67%
Div Incr Years0
Div Non Decr Years4
NVJP.DE Yearly Dividends per shareNVJP.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

NVJP pays out 93.29% of its income as dividend. This is not a sustainable payout ratio.
NVJP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP93.29%
EPS Next 2Y13.5%
EPS Next 3Y11.09%
NVJP.DE Yearly Income VS Free CF VS DividendNVJP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B
NVJP.DE Dividend Payout.NVJP.DE Dividend Payout, showing the Payout Ratio.NVJP.DE Dividend Payout.PayoutRetained Earnings

UMICORE

FRA:NVJP (11/13/2025, 7:00:00 PM)

17.36

+0.23 (+1.34%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)02-03 2026-02-03/amc
Inst Owners35.32%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.28B
Revenue(TTM)16.10B
Net Income(TTM)128.82M
Analysts66.67
Price Target15.14 (-12.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.14%
Yearly Dividend0.8
Dividend Growth(5Y)0.67%
DP93.29%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.17%
PT rev (3m)9.14%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.3%
EPS NY rev (3m)23.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-0.45%
Valuation
Industry RankSector Rank
PE 15.36
Fwd PE 12.71
P/S 0.27
P/FCF 75.83
P/OCF 9.1
P/B 2.09
P/tB 2.57
EV/EBITDA 8.63
EPS(TTM)1.13
EY6.51%
EPS(NY)1.37
Fwd EY7.87%
FCF(TTM)0.23
FCFY1.32%
OCF(TTM)1.91
OCFY10.98%
SpS65.35
BVpS8.29
TBVpS6.75
PEG (NY)0.82
PEG (5Y)N/A
Graham Number14.52
Profitability
Industry RankSector Rank
ROA 1.5%
ROE 6.3%
ROCE 8.18%
ROIC 6.4%
ROICexc 8.19%
ROICexgc 9.07%
OM 2.57%
PM (TTM) 0.8%
GM 7.76%
FCFM 0.35%
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
F-Score5
Asset Turnover1.87
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 50.79
Debt/EBITDA 3.22
Cap/Depr 144.97%
Cap/Sales 2.57%
Interest Coverage 4.12
Cash Conversion 67.19%
Profit Quality 43.79%
Current Ratio 1.37
Quick Ratio 0.72
Altman-Z 2.81
F-Score5
WACC6.1%
ROIC/WACC1.05
Cap/Depr(3y)224.12%
Cap/Depr(5y)196.78%
Cap/Sales(3y)3.57%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.12%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%14.29%
EPS Next Y18.79%
EPS Next 2Y13.5%
EPS Next 3Y11.09%
EPS Next 5Y10.31%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-0.72%
Revenue Next Year-2.96%
Revenue Next 2Y2%
Revenue Next 3Y1.1%
Revenue Next 5Y2.05%
EBIT growth 1Y136.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.86%
EBIT Next 3Y23.57%
EBIT Next 5Y16.7%
FCF growth 1Y136.84%
FCF growth 3Y-30.19%
FCF growth 5YN/A
OCF growth 1Y-3.36%
OCF growth 3Y-11.62%
OCF growth 5Y12.64%

UMICORE / NVJP.DE FAQ

What is the ChartMill fundamental rating of UMICORE (NVJP.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NVJP.DE.


What is the valuation status for NVJP stock?

ChartMill assigns a valuation rating of 5 / 10 to UMICORE (NVJP.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for UMICORE?

UMICORE (NVJP.DE) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for NVJP stock?

The Price/Earnings (PE) ratio for UMICORE (NVJP.DE) is 15.36 and the Price/Book (PB) ratio is 2.09.


What is the financial health of UMICORE (NVJP.DE) stock?

The financial health rating of UMICORE (NVJP.DE) is 3 / 10.